JNJ · NYSE · Pharmaceuticals
Stock since the trade -6.0% · S&P 500 -0.1% · to Oct 1Traded 49 days after resultsStock at its 52-week high
48K → 25K shares held−47% of their stake
Johnson & Johnson's WW Chair, MedTech sold $6.19M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade -6.0% · S&P 500 -0.1% · to Oct 1Traded 49 days after resultsStock at its 52-week high
37K → 25K shares held−30% of their stake
Johnson & Johnson's WW Chair, MedTech sold $3.04M of Johnson & Johnson shares. Nobody planned it ahead of time.
Officer plans to sell ~$9.23M of Johnson & Johnson
Planned, from payStock since the trade -1.4% · S&P 500 -1.1% · to Oct 1Traded 33 days after resultsStock within 2% of its 52-week high
209K → 194K shares held−7% of their stake
Johnson & Johnson's WWC. Innovative Medicine sold $3.95M of Johnson & Johnson shares. Nobody planned it ahead of time.
Officer plans to sell ~$3.95M of Johnson & Johnson
Planned, from payStock since the trade -1.3% · S&P 500 -1.8% · to Oct 1Traded 29 days after resultsStock within 2% of its 52-week high
378K → 276K shares held−27% of their stake
The boss of Johnson & Johnson sold $26.7M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade -1.3% · S&P 500 -1.8% · to Oct 1Traded 29 days after resultsStock within 2% of its 52-week high
399K → 378K shares held−5% of their stake
The boss of Johnson & Johnson sold $5.5M of Johnson & Johnson shares. Nobody planned it ahead of time.
Officer plans to sell ~$32.2M of Johnson & Johnson
Planned, from payStock since the trade +0.4% · S&P 500 -0.8% · to Oct 1Traded 21 days after resultsStock within 4% of its 52-week high
324K → 282K shares held−13% of their stake
The boss of Johnson & Johnson sold $10.8M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +0.4% · S&P 500 -0.8% · to Oct 1Traded 21 days after resultsStock within 4% of its 52-week high
282K → 276K shares held−2% of their stake
The boss of Johnson & Johnson sold $1.69M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +0.7% · S&P 500 -0.6% · to Oct 1Traded 22 days after resultsStock within 4% of its 52-week high
33K → 24K shares held−28% of their stake
Johnson & Johnson's Chief Legal Officer sold $2.41M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +0.7% · S&P 500 -0.6% · to Oct 1Traded 22 days after resultsStock within 4% of its 52-week high
24K → 17K shares held−28% of their stake
Johnson & Johnson's Chief Legal Officer sold $1.68M of Johnson & Johnson shares. Nobody planned it ahead of time.
Officer plans to sell ~$4.09M of Johnson & Johnson
Planned, from payInsider plans to sell ~$12.4M of Johnson & Johnson
Planned, from payStock since the trade +4.0% · S&P 500 +3.0% · to Oct 1Traded 5 days after resultsStock 51% above its 52-week low and 7% below its high
46K → 23K shares held−50% of their stake
Johnson & Johnson's Global Corp Affairs sold $5.79M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +8.5% · S&P 500 +3.6% · to Oct 1Traded 58 days after resultsStock within 5% of its 52-week high
124K → 114K shares held−8% of their stake
Johnson & Johnson's Chief TO and Risk Officer sold $2.41M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +4.1% · S&P 500 +11.4% · to Oct 1Traded 37 days after resultsStock at its 52-week high, after a 14% rise in the previous month
28K → 24K shares held−15% of their stake
Johnson & Johnson's VP Corporate Controller sold $1.01M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.7% · S&P 500 +10.8% · to Oct 1Traded 30 days after resultsStock within 2% of its 52-week high, after a 17% rise in the previous month
27K → 25K shares held−5% of their stake
Johnson & Johnson's WW Chair, MedTech sold $325K of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
72K → 39K shares held−46% of their stake
The money chief of Johnson & Johnson sold $8.1M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
39K → 14K shares held−64% of their stake
The money chief of Johnson & Johnson sold $6.06M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
58K → 39K shares held−33% of their stake
The money chief of Johnson & Johnson sold $4.68M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
51K → 39K shares held−24% of their stake
The money chief of Johnson & Johnson sold $2.93M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +5.6% · S&P 500 +11.3% · to Oct 1Traded 28 days after resultsStock at its 52-week high, after a 20% rise in the previous month
40K → 27K shares held−34% of their stake
Johnson & Johnson's WW Chair, MedTech sold $3.33M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
43K → 13K shares held−70% of their stake
Johnson & Johnson's Innovative Medicine, R&D sold $7.27M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +12.1% · to Oct 1Traded 23 days after resultsStock within 1% of its 52-week high, after an 18% rise in the previous month
47K → 25K shares held−47% of their stake
Johnson & Johnson's CIO sold $5.41M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
35K → 13K shares held−63% of their stake
Johnson & Johnson's Innovative Medicine, R&D sold $5.28M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +5.6% · S&P 500 +11.3% · to Oct 1Traded 28 days after resultsStock at its 52-week high, after a 20% rise in the previous month
36K → 27K shares held−25% of their stake
Johnson & Johnson's WW Chair, MedTech sold $2.2M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
46K → 26K shares held−44% of their stake
Johnson & Johnson's CIO sold $4.98M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +12.1% · to Oct 1Traded 23 days after resultsStock within 1% of its 52-week high, after an 18% rise in the previous month
44K → 25K shares held−44% of their stake
Johnson & Johnson's CIO sold $4.72M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
29K → 23K shares held−21% of their stake
Johnson & Johnson's Global Corp Affairs sold $1.51M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +6.3% · S&P 500 +11.9% · to Oct 1Traded 27 days after resultsStock within 1% of its 52-week high, after a 17% rise in the previous month
13K → 11K shares held−18% of their stake
Johnson & Johnson's Innovative Medicine, R&D sold $555K of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +16.8% · S&P 500 +10.3% · to Oct 1Traded 5 days after resultsStock at its 52-week high
131K → 80K shares held−39% of their stake
The boss of Johnson & Johnson sold $11.3M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +16.8% · S&P 500 +10.3% · to Oct 1Traded 5 days after resultsStock at its 52-week high
80K → 31K shares held−61% of their stake
The boss of Johnson & Johnson sold $10.8M of Johnson & Johnson shares. Nobody planned it ahead of time.
Stock since the trade +24.6% · S&P 500 +12.4% · to Oct 1Traded 43 days after resultsStock at its 52-week high
598.51 → 1,848.51 shares held+209% of their stake
A board member of Johnson & Johnson spent $258K of their very own money to buy Johnson & Johnson shares. Their pile of Johnson & Johnson shares grew by 209%.
Stock since the trade +33.9% · S&P 500 +15.0% · to Oct 1Traded 3 days after resultsStock at its 52-week high
32K → 11K shares held−67% of their stake
Johnson & Johnson's Innovative Medicine, R&D sold $4.19M of Johnson & Johnson shares. Nobody planned it ahead of time.
